NewslettersHematopoiesis NewsUncategorizedCCT245718, a Dual FLT3/Aurora a Inhibitor Overcomes D835Y-Mediated Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia CellsBy Justin.choi - August 27, 2021063The ability of CCT245718 to overcome TKD-mediated resistance was evaluated in a cell line-based model of drug resistance to Fms-like tyrosine kinase 3 (FLT3) inhibitors.[British Journal of Cancer] 7992332 {7992332:DL6RLTR4} apa 50 1 166171 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract